News Image

CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma

Provided By PR Newswire

Last update: Mar 10, 2025

NEW YORK, March 10, 2025 /PRNewswire/ -- Shareholder law firm Julie & Holleman LLP is investigating the proposed $4.10 per share sale of Checkpoint Therapeutics, Inc. (Nasdaq: CKPT) to Sun Pharmaceutical Industries, Inc. The firm is concerned about conflicts relating to Checkpoint's controlling shareholder, Fortress Biotech, Inc. (Nasdaq: FBIO), which has secured special benefits in the deal.

Read more at prnewswire.com

FORTRESS BIOTECH INC

NASDAQ:FBIO (6/10/2025, 8:00:02 PM)

After market: 2.1145 +0.03 (+1.66%)

2.08

-0.05 (-2.35%)


CHECKPOINT THERAPEUTICS INC

NASDAQ:CKPT (5/29/2025, 8:00:00 PM)

After market: 4.2705 +0.01 (+0.25%)

4.26

+0.03 (+0.71%)



Find more stocks in the Stock Screener

Follow ChartMill for more